Home
  • E-mailJan.Haavik@uib.no
  • Phone+47 55 58 64 32+47 55 58 64 51
  • Visitor Address
    Jonas Lies vei 91
  • Postal Address
    Postboks 7804
    5020 Bergen

Jan Haavik is a medical doctor who graduated from the University of Bergen. After completion of an 18 month clinical internship in internal medicine, surgery and general practice, he started research in biochemistry, biophysics and molecular biology. He defended his dr. med./phd degree in biochemistry in 1989 and was appointed as full professor at Department of Biochemistry and Molecular Biology in 1993. During his entire career he has combined teaching, basic and translational neuroscience research with full-time or part-time clinical duties. He is a board certified specialist of adult psychiatry. From 2002 he has been working  a senior consultant in psychiatry at Haukeland University hospital, with a special focus on ADHD and affective disorders. He is leading the Neurotargeting Research group and the Center of Neuropsychiatric Disorders, dedicated to exploring new treatment targets for neuropsychiatric disorders. He is involved in multiple international collaborative projects, including 3 ongoing H2020 EU project and 3 previous EU-projects. Interspersed with his work in Norway, he has had multiple stays research institutions in Sweden, Scotland, Germany, France, the United States and the Netherlands. From 2011-2018 he was director of the interdisciplinary center of excellence: "KGJebsen Center for Research on Neuropsychiatric Disorders".

 

 

 

 

MED3 Third semester medicine

BMED340 Cellular and molecular neuroscience

  • 2021. Insomnia, alcohol consumption and ADHD symptoms in adults. Frontiers in Psychology.
  • 2020. Validitet og diagnostisk treffsikkerhet ved bruk av screeningverktøy for ADHD hos voksne. Best Practise Nordic.
  • 2020. Sex differences in parent–offspring recurrence of attention-deficit/hyperactivity disorder. Journal of Child Psychology and Psychiatry. 1-9.
  • 2020. Inhibition of Tryptophan Hydroxylases and Monoamine Oxidase-A by the Proton Pump Inhibitor, Omeprazole—In Vitro and In Vivo Investigations. Frontiers in Pharmacology.
  • 2020. Discovery and biological characterization of a novel scaffold for potent inhibitors of peripheral serotonin synthesis. Future Medicinal Chemistry. 1461-1474.
  • 2020. Diet quality, stress and common mental health problems: A cohort study of 121,008 adults. Clinical Nutrition. 1-6.
  • 2020. Current and Retrospective Childhood Ratings of Emotional Fluctuations in Adults With ADHD. Frontiers in Psychology.
  • 2020. Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure. 1-19.
  • 2020. Attention-deficit/hyperactivity disorder; sex differences in psychiatric comorbidity and transgenerational recurrence risks : A population-based study using Norwegian registry data.
  • 2020. Alcohol and drug use disorders in adult attention-deficit/hyperactivity disorder: Prevalence and associations with attention-deficit/hyperactivity disorder symptom severity and emotional dysregulation. . World Journal of Psychiatry (WJP). 202-211.

More information in national current research information system (CRIStin)

Jan Haavik completed his medical education at the University of Bergen in 1983. As a student, he started his research career in biochemistry, biophysics and molecular biology. He conducted a tour of Bergen and the municipalities of Agder, graduated from the University of Bergen in 1989, and was employed as a professor, 34, at the present Institute of Biomedicine in 1993. In the period 1986-2014 he had nine shorter and longer research stays at outstanding research institutions in Sweden, Scotland, Germany, France, the United States and the Netherlands. From 2002 he has had a 20% position as a general practitioner in psychiatry, first at Øyane DPS and later at Kronstad DPS, both affiliated with Helse Bergen.